Skip to main content

Video commentaries

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Expert commentaries from clinicians and researchers on clinical studies, guidelines, and topical issues in rheumatology.


24-10-2018 | Pediatric | ACR/ARHP 2018 | Video

Expert highlights: Sangeeta Sule

Editorial board member Sangeeta Sule discusses her highlights from the pediatric rheumatology sessions at the 2018 ACR/ARHP Annual Meeting in Chicago, Illinois, USA (2:14).

23-10-2018 | Rheumatoid arthritis | ACR/ARHP 2018 | Video

Expert commentary: Influenza vaccination in RA patients

Infectious disease specialist Kevin Winthrop comments on the study by Inés Colmegna and colleagues looking at the effects of a high-dose influenza vaccine on immune response in patients with rheumatoid arthritis (6:27).

22-10-2018 | Giant cell arteritis | ACR/ARHP 2018 | Video

Axillary artery ultrasound proposed as first-line imaging test for large vessel giant cell arteritis

Berit Dalsgaard Nielsen discusses Aarhus University study findings showing the potential for ultrasound as a first-line imaging test for diagnosing large vessel inflammation in patients with suspected giant cell arteritis (4:57).

EULAR 2018

26-06-2018 | Rheumatoid arthritis | EULAR 2018 | Video

Expert commentary: Trial results on upadacitinib for the treatment of RA

Roy Fleischmann comments on the results of the SELECT-MONOTHERAPY and SELECT-NEXT trials, which provide further evidence for the benefits of upadacitinib in patients with RA (6:18).

Read the accompanying news story

14-06-2018 | TNF inhibitors | EULAR 2018 | Video

Researcher comment: Role of TNF inhibitors on need for joint replacement in RA

​​​​​​​Samuel Hawley comments on his research findings showing that TNF inhibitors might not play as big a role in the recent reduction in joint replacement procedures in patients with RA as originally thought and that additional factors are likely to be involved. (2:59)

Read the related news story

15-06-2018 | Systemic lupus erythematosus | EULAR 2018 | Video

Expert commentary: Promising results with herpes zoster vaccine in SLE patients

Thomas Dörner comments on study results demonstrating that a live attenuated herpes zoster vaccine is well tolerated and provokes an antibody response in patients with SLE (5:14).

Read the accompanying news story here

BSR 2018

03-05-2018 | Juvenile idiopathic arthritis | Conferences | Video

Managing JIA-associated uveitis: The SHARE recommendations

In this video, Athimalaipet Ramanan gives an overview of the key points from the SHARE initiative consensus recommendations on the screening, diagnosis, and management of juvenile idiopathic arthritis-associated uveitis.


09-11-2017 | Juvenile idiopathic arthritis | ACR/ARHP 2017 | Video

Expert commentary: Tapping into technology to manage juvenile idiopathic arthritis

Editorial Board member Sangeeta Sule discusses a trial of an online self-management tool for adolescents with juvenile idiopathic arthritis, and the role of technology and education to manage the condition.

07-11-2017 | ACR/ARHP 2017 | Video

The effects of obesity on the outcomes of rheumatic disorders

Margaret Tsai provides independent comment on three studies exploring the effects of obesity in patients with rheumatic diseases.

08-11-2017 | Osteoporosis | ACR/ARHP 2017 | Video

Expert commentary: Bisphosphonate drug holidays and fracture risk

Linda Russell gives an independent comment on a study showing that suspending bisphosphonate treatment for more than 2 years is associated with increased fracture risk.

Read the accompanying news story

EULAR 2017

16-06-2017 | EULAR 2017 | Video

EULAR 2017 highlights: Jürgen Braun

Jürgen Braun talks about his spondyloarthritis highlights from the EULAR meeting.

This activity is financially supported by Novartis Pharma AG.

15-06-2017 | EULAR 2017 | Video

EULAR 2017 highlights: Peter Nash

Peter Nash discusses his rheumatology highlights from Madrid, including new data on oral small molecules and IL-17 inhibitors.

This activity is financially supported by Novartis Pharma AG.

16-06-2017 | Psoriatic arthritis | EULAR 2017 | Video

EULAR 2017 highlights: Philip Mease

Medicine Matters rheumatology editorial board member Philip Mease summarizes research on new therapeutic agents for psoriatic arthritis presented at the meeting.

This activity is financially supported by Novartis Pharma AG.

Image Credits